Skip to main content
. 2016 Apr 29;95(17):e3452. doi: 10.1097/MD.0000000000003452

FIGURE 6.

FIGURE 6

Systemic metastasis-free survival according to SMAD4 expression and SUVmax value, 4.5. Loss of SMAD4 was associated with earlier systemic metastasis in resected left-sided pancreatic cancer (22.3 months [95% CI: 8.9–35.7] vs 62.5 months [95% CI: 46.7–78.3], P = 0.022) (A), and SUVmax >4.5 was also related to early systemic metastasis (14.3 months [95% CI: 8.0–20.5] vs 66.1 months [95% CI: 47.3–84.8], P < 0.001) (B). CI = confidence interval, SUVmax = maximum standardized uptake.